• January, lsotopia promoted inclusion of F-18-DOPA in the Israeli medical health insurance for reimbursement for diagnosis of neuroendocrine tumors-The introduction of F-DOPA into the health basket for the diagnosis of neuroendocrine tumors will allow more accurate diagnosis and greater availability for a variety of tumors such as: pheochromocytoma / paraganglioma / neuroblastoma and insulinemia in infants. Since it is manufactured by Isotopia, the availability is greater and high specificity and sensitivity is high, this allow our product to be accessible to the physician and patient.

A significant part of our vision is to enable patients to benefit from the most advanced and accurate imaging materials. This was possible by introducing this diagnosis into the governmental health insurance.